+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

P

Actively Recruiting

Researchers are evaluating the efficacy, safety, and tolerability of subcutaneous treatment with lunsekimig compared with placebo in adults aged 40 to 80 years who have inadequately controlled Chronic Obstructive Pulmonary Disease COPD characterized by an eosinophilic phenotype. This Phase 2bPhase 3 study includes participants with a history of COPD, ongoing symptoms despite treatment, and specific lung function and blood eosinophil criteria. Participants will be randomly assigned to one of three groups lunsekimig dose regimen A, lunsekimig dose regimen B, or a placebo group. All treatments are given as subcutaneous injections during a 48-week treatment period. The study consists of a screening period up to 4 weeks, followed by the 48-week randomized treatment, and then an approximately 8-week follow-up period, totaling up to 60 weeks of participation. During the study, participants will undergo lung function tests, symptom and quality of life questionnaires, and blood tests to monitor eosinophil counts and drug levels. The main outcome measured is the annualized rate of moderate-to-severe COPD exacerbations over 48 weeks. Additional assessments include changes in lung function, symptom scores, safety events, and antibody development. Safety monitoring continues through the follow-up period after treatment ends.

Age: 40Years - 80YearsAll GendersPhase 3
314 locations
S

Actively Recruiting

Healthy Volunteer

Indigenous people living in rural and remote communities across Manitoba, British Columbia, Alberta, Saskatchewan, and Ontario face higher risks of Chronic Kidney Disease CKD, diabetes, and high blood pressure compared to the general population. This research aims to perform point-of-care testing to identify these conditions early and provide tailored treatment plans. The study seeks to develop a durable CKD surveillance system to reduce the burden of kidney disease and kidney failure in these communities. Participants will receive point-of-care screening conducted by a registered nurse, including demographic and physical data collection, and blood and urine testing. Results are provided during the appointment, and those at high risk of kidney failure are referred to nephrologists, while others receive guidance for primary care follow-up. This approach supports early diagnosis and treatment in both adults and children. Throughout the study, participants will undergo assessments of kidney function biomarkers, diabetes status, blood pressure, and kidney failure risk during the screening visit. The process includes real-time testing and counseling, aiming to ensure ongoing care and monitoring. The total involvement includes one screening day, with follow-up care coordinated based on individual risk levels to help prevent CKD progression and kidney failure.

Age: 10Years - 80YearsAll Genders
3 locations